Merck & Co., Inc. (NYSE:MRK) Q2 2024 Earnings Call Transcript

Merck & Co., Inc. (NYSE:MRK) Q2 2024 Earnings Call Transcript July 30, 2024

Merck & Co., Inc. beats earnings expectations. Reported EPS is $2.28, expectations were $2.17.

Operator: Thank you for standing by. Welcome to the Merck & Co. Q2 Sales and Earnings Conference Call [Operator Instructions]. This call is being recorded. If you have any objections, you may disconnect at this time. I would now like to turn the call over to Mr. Peter Dannenbaum, Senior Vice President, and Investor...